- Home
- CPBI vs LEXX Comparison
CPBI vs LEXX Comparison
Compare CPBI & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPBI
- LEXX
- Stock Information
- Founded
- CPBI 2023
- LEXX 2004
- Country
- CPBI United States
- LEXX Canada
- Employees
- CPBI N/A
- LEXX N/A
- Industry
- CPBI
- LEXX Biotechnology: Pharmaceutical Preparations
- Sector
- CPBI
- LEXX Health Care
- Exchange
- CPBI Nasdaq
- LEXX Nasdaq
- Market Cap
- CPBI 53.6M
- LEXX 43.5M
- IPO Year
- CPBI N/A
- LEXX N/A
- Fundamental
- Price
- CPBI $14.45
- LEXX $2.16
- Analyst Decision
- CPBI
- LEXX Strong Buy
- Analyst Count
- CPBI 0
- LEXX 2
- Target Price
- CPBI N/A
- LEXX $11.00
- AVG Volume (30 Days)
- CPBI 5.2K
- LEXX 192.0K
- Earning Date
- CPBI 01-01-0001
- LEXX 01-10-2025
- Dividend Yield
- CPBI N/A
- LEXX N/A
- EPS Growth
- CPBI N/A
- LEXX N/A
- EPS
- CPBI 0.89
- LEXX N/A
- Revenue
- CPBI $18,262,000.00
- LEXX $464,278.00
- Revenue This Year
- CPBI N/A
- LEXX $73.01
- Revenue Next Year
- CPBI N/A
- LEXX $48.40
- P/E Ratio
- CPBI $16.10
- LEXX N/A
- Revenue Growth
- CPBI 37.54
- LEXX 105.24
- 52 Week Low
- CPBI $9.65
- LEXX $1.20
- 52 Week High
- CPBI $15.00
- LEXX $6.85
- Technical
- Relative Strength Index (RSI)
- CPBI 53.82
- LEXX 41.53
- Support Level
- CPBI $14.32
- LEXX $2.00
- Resistance Level
- CPBI $14.52
- LEXX $2.54
- Average True Range (ATR)
- CPBI 0.12
- LEXX 0.25
- MACD
- CPBI -0.03
- LEXX -0.01
- Stochastic Oscillator
- CPBI 42.86
- LEXX 12.94
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.